Sign in

CIK 0001401914

  • Non-accelerated filer
  • Smaller reporting company

Dare Bioscience, Inc.

Sign in to watch
Ticker
DARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
204139823
Phone
+1 858-926-7655
Business address
3655 NOBEL DRIVE, SUITE 260, SAN DIEGO, CA, 92122
Former names
Cerulean Pharma Inc., Tempo Pharmaceuticals Inc
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Exercise or conversion President and CEO acquired 30,000 shares (option exercise)
  10. 4 Open-market buy 10% owner bought 944,290 shares at $7.00 ($6,610,030)
  11. 4 Open-market buy Director bought 18,869 shares at $7.00 ($132,083)
  12. 4 Open-market buy 10% owner bought 827,456 shares at $7.00 ($5,792,192)
  13. 4 Open-market buy 10% owner bought 1,470,582 shares at $7.00 ($10,294,074)
  14. 4 Conversion 10% owner acquired 1,432,101 shares (conversion)
  15. 4 Open-market buy Director bought 1,470,582 shares at $7.00 ($10,294,074)
  16. 4 Open-market buy 10% owner bought 733,445 shares at $7.00 ($5,134,115)
  17. 4 Open-market buy Director bought 733,445 shares at $7.00 ($5,134,115)
  18. 4 Open-market buy Former 10% Owner bought 106,224 shares at $7.00 ($743,568)
  19. 4 Conversion Former 10% Owner acquired 464,365 shares (conversion)
  20. 4 Derivatives Options or other derivatives

Page 11 of 13 · 241 filings